Healthcare - Biotechnology - NASDAQ - US
$ 1.54
-8.33 %
$ 103 M
Market Cap
-0.77
P/E
BALANCE SHEET
375 M
ASSETS
172 M
LIABILITIES
203 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Generation Bio Co.
| Current Assets | 273 M |
| Cash & Short-Term Investments | 264 M |
| Receivables | 4.15 M |
| Other Current Assets | 4.11 M |
| Non-Current Assets | 102 M |
| Long-Term Investments | 0 |
| PP&E | 95.7 M |
| Other Non-Current Assets | 6.49 M |
| Current Liabilities | 39.9 M |
| Accounts Payable | 2.35 M |
| Short-Term Debt | 8.12 M |
| Other Current Liabilities | 29.4 M |
| Non-Current Liabilities | 132 M |
| Long-Term Debt | 89.8 M |
| Other Non-Current Liabilities | 41.9 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 66.4 | 93.2 | 375.1 | 62.9 | 15.1 | 7.3 |
| Short Term Investments | 197.9 | 185.9 | 0 | 199.4 | 0 | 67.6 |
| Receivables | 4.1 | 0.4 | 0 | 0 | 0.4 | 1.3 |
| Inventory | 1 | 0 | 0 | 0 | 1 | 0 |
| Other Current Assets | 4.1 | 7.5 | 7.4 | 10.8 | 2.6 | 0.8 |
| Total Current Assets | 272.6 | 287.0 | 379.2 | 267.7 | 18.2 | 76.9 |
| PP&E | 95.7 | 81.4 | 91.0 | 23.8 | 21.8 | 4.5 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 5.7 | 5.7 | 2.1 | 2.1 | 2.1 |
| Other Long Term Assets | 6.5 | 2.1 | 0.9 | 0.6 | 87 K | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 374.8 | 376.3 | 476.8 | 294.2 | 42.1 | 83.5 |
| LIABILITIES | ||||||
| Accounts Payable | 2.3 | 0.7 | 2.0 | 0.3 | 2.3 | 1.7 |
| Short Term Debt | 8.1 | 14.2 | 9.2 | 0 | 0 | 0 |
| Other Current Liabilities | 16.5 | 4.3 | 7.6 | 11.0 | 6.9 | 4.9 |
| Total Current Liabilities | 39.9 | 19.1 | 18.8 | 11.2 | 9.2 | 6.6 |
| Long Term Debt | 89.8 | 74.6 | 76.2 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 115.6 | 115.6 |
| Total Liabilities | 171.6 | 93.8 | 95.0 | 26.1 | 140.7 | 125.1 |
| EQUITY | ||||||
| Common Stock | 7 K | 6 K | 6 K | 5 K | 1 K | 1 K |
| Retained Earnings | (571.4) | (444.8) | (308.1) | (189.0) | (108.5) | (47.1) |
| Other Accumulative Comprehensive Income/Loss | 0.3 | 83 K | 0 | 9 K | (115.6) | 9 K |
| Total Equity | 203.1 | 282.5 | 381.7 | 268.0 | (98.6) | (41.6) |
| Total Liabilities and Equity | 374.8 | 376.3 | 476.8 | 294.2 | 42.1 | 83.5 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 64.5 | 58.1 | 56.3 | 27.3 | 46.2 | 19.7 |